Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Short term Debt (2021 - 2025)

Journey Medical's Short term Debt history spans 4 years, with the latest figure at $5.6 million for Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt changed N/A year-over-year to $5.6 million, compared with a TTM value of $5.6 million through Sep 2025, changed N/A, and an annual FY2022 reading of $2.9 million, up 263.05% over the prior year.
  • Short term Debt for Q3 2025 was $5.6 million at Journey Medical, up from $3.8 million in the prior quarter.
  • The five-year high for Short term Debt was $9.9 million in Q2 2023, with the low at $812000.0 in Q4 2021.
  • Average Short term Debt over 4 years is $5.0 million, with a median of $3.8 million recorded in 2025.
  • Biggest YoY gain for Short term Debt was 263.05% in 2022; the steepest drop was 263.05% in 2022.
  • Tracing DERM's Short term Debt over 4 years: stood at $812000.0 in 2021, then surged by 263.05% to $2.9 million in 2022, then soared by 237.25% to $9.9 million in 2023, then plummeted by 43.42% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Short term Debt are $5.6 million (Q3 2025), $3.8 million (Q2 2025), and $1.9 million (Q1 2025).